• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

4A5:GR

40.755 EUR 0.545 1.32%

As of 02:13:57 ET on 07/28/2014.

Snapshot for Arseus NV (4A5)

Open: 40.722 Day's Range: 40.722 - 40.755 Volume: 0
Previous Close: 41.300 52wk Range: 18.530 - 43.800 1-Yr Rtn: +128.09%

Stock Chart for 4A5

No chart data available.
  • 4A5:GR 40.722
  • 1D
  • 1M
  • 1Y
41.300
Interactive 4A5 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4A5

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 19.9096
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 2.0470
Est. PEG Ratio -
Market Cap (M EUR) 1,280.99
Shares Outstanding (M) 31.43
30 Day Average Volume 106
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.77%
Cash Dividend (EUR) 0.5400
Dividend Ex-Date 05/14/2014
5 Year Dividend Growth 19.14%
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4A5

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for 4A5

Arseus NV provides a wide range of products for the health, wellness, esthetics and ageing populations. The Company distributes and resells dental equipment, medical equipment, pharmaceuticals, and provides integrated information technology solutions for healthcare professionals.

Gerardus Van Jeveren "Ger"Chief Executive OfficerJan PeetersChief Financial Officer
Dirk Van LerbergheCEO:CorilusMario HuygheCEO:Healthcare Solutions
More Company Profile & Key Executives for 4A5

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil